RASopathic alopecia: hair changes associated with vemurafenib therapy

J Am Acad Dermatol. 2015 Apr;72(4):738-41. doi: 10.1016/j.jaad.2015.01.011.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alopecia / chemically induced*
  • Alopecia / pathology
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Clobetasol / therapeutic use
  • Female
  • Hair Follicle / enzymology
  • Hair Follicle / pathology
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Male
  • Melanoma / drug therapy
  • Melanoma / enzymology
  • Melanoma / secondary*
  • Middle Aged
  • Molecular Targeted Therapy
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / physiology
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Proto-Oncogene Proteins B-raf / physiology
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / enzymology
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Vemurafenib

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Indoles
  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Vemurafenib
  • Clobetasol
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf